Fund Overview of Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw
-
₹161.0 CrAUM
-
₹12.02NAV
-
1.11%Expense Ratio
-
EquityFund Category
Returns of Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 1.33% | NA | 6.12% |
| 6 Months | 13.72% | NA | 12.92% |
| 1 Year | 4.20% | 4.20% | 6.04% |
Asset Allocation
equities
100.06%Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw is one Equity mutual fund offered by Tata Mutual Fund. Launched on 26 Apr 2024, the fund aims Long Term Capital Appreciation. Investment in equity and equity related instruments comprised in Nifty MidSmall Healthcare Index. It manages assets worth ₹161.0 crore as on Thu Jul 31, 2025. The expense ratio stands at 1.11%. Fund Manager Manager Education Fund Manager Manager EducationAbout Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw
The portfolio allocation consists of 100.06% in equities. Managed by Rakesh Prajapati, it has delivered a return of 4.20% in the last year, a total return since inception of 19.28%.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -6.24% | -5.70% | 0.12% | 27.75% | 17.34% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -6.31% | -5.91% | -0.71% | 26.66% | 16.30% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -4.06% | -2.75% | 1.52% | 23.43% | 14.38% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -4.17% | -3.09% | 0.20% | 21.79% | 12.77% |
More funds from Tata Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Tata India Pharma & Healthcare Fund Regular-growth
|
₹1,339 | -5.95% | -6.15% | -4.03% | -4.22% | 21.21% |
|
Tata India Pharma & Healthcare Fund Direct-growth
|
₹1,339 | -5.83% | -5.80% | -3.32% | -2.75% | 23.02% |
|
Tata India Pharma & Healthcare Fund Regular-idcw
|
₹1,339 | -5.95% | -6.15% | -4.03% | -4.22% | 21.21% |
|
Tata India Pharma & Healthcare Fund Direct-idcw
|
₹1,339 | -5.83% | -5.80% | -3.32% | -2.75% | 23.02% |
|
Tata Nifty Midsmall Healthcare Index Fund Regular - Growth
|
₹161 | -7.34% | -6.36% | -6.13% | -2.00% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct - Growth
|
₹161 | -7.29% | -6.22% | -5.84% | -1.39% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct - Idcw
|
₹161 | -7.29% | -6.22% | -5.84% | -1.39% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹37.74 | 26.66% | 16.30% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹40.85 | 27.75% | 17.34% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹33.30 | 23.43% | 14.38% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹30.11 | 21.79% | 12.77% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹144.77 | 22.81% | - | - |
| ICICI Prudential Nifty Pharma Index Fund Direct - Growth |
₹95 | ₹16.99 | 21.52% | - | - |
| ICICI Prudential Nifty Pharma Index Fund - Growth |
₹95 | ₹16.65 | 20.76% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹14.52 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Max Healthcare Institute Ltd | Healthcare | 15.01% | ₹24.17 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.94% | ₹15.91 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.94% | ₹15.91 Cr |
| Lupin Ltd | Healthcare | 9.51% | ₹15.10 Cr |
| Lupin Ltd | Healthcare | 9.35% | ₹15.09 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.63% | ₹15.08 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.89% | ₹14.35 Cr |
| Lupin Ltd | Healthcare | 8.86% | ₹14.18 Cr |
| Lupin Ltd | Healthcare | 8.86% | ₹14.18 Cr |
| Lupin Ltd | Healthcare | 8.81% | ₹13.79 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.56% | ₹13.60 Cr |
| Laurus Labs Ltd | Healthcare | 8.00% | ₹12.71 Cr |
| Lupin Ltd | Healthcare | 7.56% | ₹12.17 Cr |
| Laurus Labs Ltd | Healthcare | 7.44% | ₹12.01 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.24% | ₹11.66 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹11.06 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹11.06 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.37% | ₹10.28 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.15% | ₹9.77 Cr |
| Laurus Labs Ltd | Healthcare | 6.23% | ₹9.76 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.94% | ₹9.59 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.99% | ₹9.51 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹9.51 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹9.51 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹9.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹9.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.82% | ₹9.11 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.70% | ₹9.05 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.77% | ₹9.04 Cr |
| Laurus Labs Ltd | Healthcare | 5.55% | ₹8.93 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.44% | ₹8.78 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.60% | ₹8.77 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.31% | ₹8.50 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.31% | ₹8.50 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.21% | ₹8.39 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.17% | ₹8.32 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.25% | ₹8.22 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.03% | ₹8.04 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.03% | ₹8.04 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.73% | ₹7.63 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.70% | ₹7.57 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.62% | ₹7.34 Cr |
| Biocon Ltd | Healthcare | 4.44% | ₹7.17 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.39% | ₹7.06 Cr |
| Biocon Ltd | Healthcare | 4.40% | ₹6.98 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹6.67 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹6.67 Cr |
| Biocon Ltd | Healthcare | 3.81% | ₹6.13 Cr |
| Biocon Ltd | Healthcare | 3.90% | ₹6.11 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.75% | ₹6.05 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.67% | ₹5.82 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.55% | ₹5.55 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.32% | ₹5.35 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹5.30 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹5.30 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹5.27 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹5.27 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.29% | ₹5.15 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.13% | ₹5.06 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.99% | ₹4.81 Cr |
| Gland Pharma Ltd | Healthcare | 3.02% | ₹4.73 Cr |
| Abbott India Ltd | Healthcare | 2.91% | ₹4.70 Cr |
| Abbott India Ltd | Healthcare | 2.91% | ₹4.68 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹4.58 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹4.58 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹4.57 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹4.57 Cr |
| Abbott India Ltd | Healthcare | 2.91% | ₹4.56 Cr |
| Abbott India Ltd | Healthcare | 2.82% | ₹4.51 Cr |
| Abbott India Ltd | Healthcare | 2.82% | ₹4.51 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.79% | ₹4.51 Cr |
| Abbott India Ltd | Healthcare | 2.82% | ₹4.47 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.79% | ₹4.44 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.75% | ₹4.44 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.77% | ₹4.39 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.68% | ₹4.32 Cr |
| Gland Pharma Ltd | Healthcare | 2.66% | ₹4.29 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.67% | ₹4.23 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.70% | ₹4.23 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.63% | ₹4.21 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.63% | ₹4.21 Cr |
| Gland Pharma Ltd | Healthcare | 2.60% | ₹4.20 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.65% | ₹4.15 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹4.09 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹4.09 Cr |
| Gland Pharma Ltd | Healthcare | 2.55% | ₹4.05 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.45% | ₹3.96 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.42% | ₹3.84 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.39% | ₹3.79 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.32% | ₹3.74 Cr |
| Wockhardt Ltd | Healthcare | 2.39% | ₹3.74 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.38% | ₹3.73 Cr |
| Syngene International Ltd | Healthcare | 2.28% | ₹3.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹3.65 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹3.57 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹3.57 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.23% | ₹3.56 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.23% | ₹3.56 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.21% | ₹3.55 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.27% | ₹3.55 Cr |
| Syngene International Ltd | Healthcare | 2.19% | ₹3.53 Cr |
| Wockhardt Ltd | Healthcare | 2.22% | ₹3.53 Cr |
| Syngene International Ltd | Healthcare | 2.25% | ₹3.52 Cr |
| Piramal Pharma Ltd | Healthcare | 2.25% | ₹3.52 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.25% | ₹3.52 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.16% | ₹3.49 Cr |
| Piramal Pharma Ltd | Healthcare | 2.15% | ₹3.47 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.17% | ₹3.44 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.12% | ₹3.42 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.11% | ₹3.39 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.13% | ₹3.39 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.14% | ₹3.35 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.07% | ₹3.33 Cr |
| Global Health Ltd | Healthcare | 2.11% | ₹3.31 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹3.30 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹3.30 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.10% | ₹3.29 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.02% | ₹3.24 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.02% | ₹3.24 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.00% | ₹3.23 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.98% | ₹3.19 Cr |
| Piramal Pharma Ltd | Healthcare | 1.98% | ₹3.18 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹3.16 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹3.16 Cr |
| Global Health Ltd | Healthcare | 1.95% | ₹3.15 Cr |
| Piramal Pharma Ltd | Healthcare | 1.98% | ₹3.15 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.94% | ₹3.10 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.94% | ₹3.10 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.91% | ₹3.08 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.91% | ₹3.06 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.91% | ₹3.06 Cr |
| Wockhardt Ltd | Healthcare | 1.89% | ₹3.06 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.94% | ₹3.04 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.93% | ₹3.02 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.88% | ₹3.02 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.90% | ₹3.02 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.84% | ₹2.97 Cr |
| Global Health Ltd | Healthcare | 1.87% | ₹2.97 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.86% | ₹2.96 Cr |
| Global Health Ltd | Healthcare | 1.79% | ₹2.89 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹2.87 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹2.87 Cr |
| Granules India Ltd | Healthcare | 1.61% | ₹2.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.57% | ₹2.54 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.60% | ₹2.54 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹2.45 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹2.45 Cr |
| Granules India Ltd | Healthcare | 1.50% | ₹2.42 Cr |
| Natco Pharma Ltd | Healthcare | 1.51% | ₹2.39 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹2.36 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹2.36 Cr |
| Natco Pharma Ltd | Healthcare | 1.46% | ₹2.35 Cr |
| Pfizer Ltd | Healthcare | 1.45% | ₹2.28 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹2.28 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹2.28 Cr |
| Pfizer Ltd | Healthcare | 1.40% | ₹2.26 Cr |
| Granules India Ltd | Healthcare | 1.43% | ₹2.24 Cr |
| Pfizer Ltd | Healthcare | 1.41% | ₹2.23 Cr |
| Natco Pharma Ltd | Healthcare | 1.38% | ₹2.23 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹2.22 Cr |
| Poly Medicure Ltd | Healthcare | 1.37% | ₹2.22 Cr |
| Natco Pharma Ltd | Healthcare | 1.37% | ₹2.19 Cr |
| Natco Pharma Ltd | Healthcare | 1.37% | ₹2.19 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.34% | ₹2.16 Cr |
| Natco Pharma Ltd | Healthcare | 1.36% | ₹2.13 Cr |
| Pfizer Ltd | Healthcare | 1.28% | ₹2.06 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.28% | ₹2.04 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.28% | ₹2.04 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.25% | ₹2.02 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.29% | ₹2.02 Cr |
| Poly Medicure Ltd | Healthcare | 1.26% | ₹2.00 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.23% | ₹1.99 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.23% | ₹1.95 Cr |
| Poly Medicure Ltd | Healthcare | 1.20% | ₹1.93 Cr |
| Granules India Ltd | Healthcare | 1.12% | ₹1.80 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.88% | ₹1.42 Cr |
| Repo | Unspecified | 0.49% | ₹0.76 Cr |
| Repo | Unspecified | 0.11% | ₹0.18 Cr |
| Repo | Unspecified | 0.03% | ₹0.05 Cr |
| Repo | Unspecified | 0.03% | ₹0.05 Cr |
| Repo | Unspecified | 0.03% | ₹0.04 Cr |
| Repo | Unspecified | 0.01% | ₹0.02 Cr |
| Net Payables | Unspecified | -0.06% | ₹-0.06 Cr |
| Net Payables | Unspecified | -0.07% | ₹-0.07 Cr |
| Net Payables | Unspecified | -0.07% | ₹-0.18 Cr |
| Net Payables | Unspecified | -0.11% | ₹-0.18 Cr |
| Net Payables | Unspecified | -0.11% | ₹-0.18 Cr |
| Net Payables | Unspecified | -0.58% | ₹-0.89 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹40.85 | 27.75% | 17.34% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹37.74 | 26.66% | 16.30% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹33.30 | 23.43% | 14.38% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹30.11 | 21.79% | 12.77% | - |
Frequently Asked Questions
Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw
What is the current AUM of Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw?
As of Thu Jul 31, 2025, Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw manages assets worth ₹161.0 crore
How has Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw performed recently?
- 3 Months: 1.33%
- 6 Months: 13.72%
What is the long-term performance of Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw?
- Since Inception: 19.28%
What is the portfolio composition of Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw?
Equity: 100.06%, Others: -0.06%.
Who manages Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw?
Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw is managed by Rakesh Prajapati from Tata Mutual Fund.
What is the market-cap allocation of Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw?
Mid Cap: 65.54%, Small Cap: 34.46%.
Which are the top companies Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw has invested in?
- Max Healthcare Institute Ltd – 15.01% of the fund's portfolio
- Fortis Healthcare Ltd – 9.94% of the fund's portfolio
- Fortis Healthcare Ltd – 9.94% of the fund's portfolio
- Lupin Ltd – 9.51% of the fund's portfolio
- Lupin Ltd – 9.35% of the fund's portfolio
Which are the major sectors Tata Nifty Midsmall Healthcare Index Fund Regular - Idcw focuses on?
- Healthcare – 600.30% of the fund's portfolio
- Unspecified – -0.30% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





